Using direct oral anticoagulants as a case study, the authors examined how delayed adoption of novel treatments could impact patient health outcomes and cost. Objective: To examine the relationship ...

Direct oral anticoagulants were associated with lower risks of ischemic stroke or systemic embolism and bleeding compared with warfarin. The study included patients with atrial fibrillation (AF) and ...

At both 6 months and 12 months follow-up, the rivaroxaban group was found to have more of these events than the apixaban group. Credit: Getty Images. In patients with atrial fibrillation and valvular ...

UAB Division of Cardiothoracic Surgery Assistant Professor Panayotis Vardas, M.D., has co-authored the article, "The Society of Thoracic Surgeons 2023 clinical practice guidelines for the surgical ...

A new study compares edoxaban anticoagulant with the standard of care in large randomized clinical trial. The anticoagulant edoxaban may be just as effective as warfarin for preventing heart attack or ...

If you don’t know someone who has experienced Atrial Fibrillation, commonly referred to as AFib, odds are you will at some point. Estimates show up to 12 million people may be affected by AFib by the ...